Logo image of DOCS

DOXIMITY INC-CLASS A (DOCS) Stock News

NYSE:DOCS - New York Stock Exchange, Inc. - US26622P1075 - Common Stock - Currency: USD

52.09  +0.15 (+0.29%)

After market: 52 -0.09 (-0.17%)

DOCS Latest News, Press Relases and Analysis

News Image
14 days ago - Chartmill

Market Monitor News May 17 (Virgin Galactic, Coinbase UP - Doximity, Applied Materials DOWN)

Markets ended the week strong, powered by trade optimism and tech momentum. But weak consumer sentiment and inflation concerns linger beneath the surface.

Mentions: NFLX TTWO AMAT SPCE ...

News Image
15 days ago - Chartmill

Top movers in Friday's pre-market session

Discover the top movers in Friday's pre-market session and stay informed about market dynamics.

Mentions: GTI GLOB EVLV AYTU ...

News Image
8 days ago - Yahoo Finance

Wall St falls as Trump tariff threats spark market uncertainty

NEW YORK (Reuters) -U.S. stocks fell on Friday, notching a weekly loss, after President Donald Trump recommended 50% tariffs on European goods, reopening a new front in global trade tensions and unleashing a fresh wave of market uncertainty. All three main Wall Street indexes pared early losses but each still ended lower and shed more than 2% for the week. Technology, communication services and consumer discretionary stocks were the biggest losers of the S&P 500's 11 subsectors.

Mentions: AAPL AMZN NVDA TSLA ...

News Image
8 days ago - Yahoo Finance

Air Products and Chemicals, Inc. (APD) Declares Quarterly Dividend

On May 22, Air Products and Chemicals, Inc. (NYSE:APD) declared a quarterly dividend of $1.79 per share, which was in line with its previous dividend. Air Products and Chemicals, Inc. (NYSE:APD) is an American multinational company that is known for its industrial gases, performance materials, and associated equipment and services. The company has maintained a […]

Mentions: APD MNTN LAD UNH ...

News Image
8 days ago - Yahoo Finance

Jim Cramer on Doximity (DOCS): “I Cannot Get Behind That”

We recently published a list of Jim Cramer Discussed These 9 Stocks Recently. In this article, we are going to take a look at where Doximity, Inc. (NYSE:DOCS) stands against other stocks that Jim Cramer discussed recently. Noting that the stock tanked after earnings on weak guidance, a caller asked for Cramer’s opinion of Doximity, […]

Mentions: IBKR OXY PATH

News Image
9 days ago - Benzinga

Jim Cramer: Rivian Better Than This Automaker, Pan American Silver Is The 'Best Silver Mine'

Rivian Automotive is better than this EV rival that missed analyst estimates of $250 million, according to Benzinga Pro.

Mentions: MRVL NVDA PAAS MAG ...

News Image
10 days ago - Yahoo Finance

5 popular annuities for retirees

Discover the benefits and considerations of annuities in retirement planning.

Mentions: AAPL LCID PLD NNN ...

News Image
11 days ago - Kuehn Law, PLLC

Kuehn Law Encourages Investors of Doximity, Inc. to Contact Law Firm

/PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Doximity, Inc. (NYSE: DOCS)...

News Image
12 days ago - Yahoo Finance

Doximity: Strong Growth but What's Next?

Digital medical platform leader Doximity reported better-than-expected results on the top and bottom lines. Free cash flow grew by more than 50% year over year, and margins are stellar. At first glance, Doximity's earnings report looked rather strong.

Mentions: DEO AMAT NVDA DELL ...

News Image
12 days ago - The Motley Fool

Doximity: Strong Growth but What's Next?

News Image
12 days ago - Benzinga

Doximity Stock 7.8% Higher After Key Trading Signal

A significant trading signal occurred for Doximity stock at a price of $49.24, after which DOCS rose up to 7.8%.

News Image
15 days ago - Chartmill

DOXIMITY INC-CLASS A (NYSE:DOCS) - A Strong Contender in Affordable Growth Stocks

DOXIMITY INC (NYSE:DOCS) is an affordable growth stock with strong profitability, zero debt, and solid earnings growth, trading at a reasonable valuation relative to peers.

News Image
15 days ago - Stocktwits

Doximity's Tepid Revenue Forecast Outweighs Q4 Beat, But Retail Traders Snap Up After-Hours Dip

The company reported a strong Q4 with 17% revenue growth but saw shares drop 20% after hours following conservative FY26 revenue and Q1 guidance that missed analyst estimates.

News Image
16 days ago - Yahoo Finance

Doximity Stock Drops 20% After Outlook Disappoints

Shares of Doximity plummeted late Thursday after the telehealth software company dished out a disappointing outlook.

News Image
16 days ago - Zacks Investment Research

Doximity (DOCS) Surpasses Q4 Earnings and Revenue Estimates

Doximity (DOCS) delivered earnings and revenue surprises of 40.74% and 3.39%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Mentions: PACS

News Image
16 days ago - Yahoo Finance

Why Nextracker Stock Skyrocketed Today

It powered well past analyst estimates for both revenue and net income. The sun was shining brightly on solar industry technology specialist Nextracker's (NASDAQ: NXT) stock on Thursday. After the company crushed analyst estimates in its latest quarterly-earnings report, satisfied investors pushed its share price up by nearly 12%, obliterating the S&P 500 index's 0.4% increase.

Mentions: NXT FMCC BIRK AEO ...

News Image
16 days ago - Chartmill

Thursday's after hours session: top gainers and losers

The US market regular session of Thursday is over, let's have a look at the top gainers and losers in the after hours session today.

Mentions: EBS GTI AXDX GLOB ...

News Image
19 days ago - Zacks Investment Research

Doximity Q4 Earnings Likely to Reflect Strong Product Momentum

Doximity's Q4 performance likely witnessed strong product-driven gains from new modules and integrated programs, though early revenue pull-forward might have tempered sequential growth.

Mentions: ALT HQY STOK

News Image
19 days ago - Chartmill

DOXIMITY INC-CLASS A (NYSE:DOCS) is setting up nicely for a breakout.

DOXIMITY INC-CLASS A (NYSE:DOCS) has a strong technical rating of 8 out of 10, indicating a potential breakout.